Aruna Bio
neural exosomes, blood-brain barrier, neuroregeneration
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
neural exosomes, blood-brain barrier, neuroregeneration
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Aruna Bio states that neurological disease can be addressed by unlocking the therapeutic potential of its proprietary neural exosome platform, which it says can cross the blood-brain barrier and may eventually deliver therapeutic doses of agents to specific cells in the central nervous system, with the goal of transforming millions of lives.
SourceArunA Bio states that exosomes are naturally occurring biologics that can target diseased cells and facilitate repair, and that this makes them a promising therapeutic approach for diseases throughout the body. The company specifically believes its proprietary neural exosomes can cross the blood-brain barrier, enabling drugs and drug combinations to reach diseased cells and treat a broad range of neurological disorders, while scalable manufacturing is critical to making this platform clinically useful.
SourceAruna Bio presents exosomes as naturally occurring biologics that can target diseased cells and facilitate repair, and states that its proprietary neural exosomes can cross the blood-brain barrier to enable drugs and drug combinations to reach diseased cells and treat a broad range of neurological disorders. The company also states a belief that clinical-scale exosome manufacturing is a key enabler for both its own therapeutic pipeline and partner drug-delivery applications.
SourceThe company’s stated belief is that neural cell-derived exosomes can serve as a cell-free therapeutic approach for central nervous system disease, including by reaching the brain and working through multiple biological effects such as reducing neuro-inflammation, promoting neuro-protection, and stimulating neuro-regeneration.
SourceThis snapshot does not contain any stated beliefs, mission, or longevity-related position from ArunaBio; it is a Namecheap parking page indicating the domain was recently registered and that the site content had not yet been created.
Source